A strategy for postponing aging indefinitely

Studies in Health Technology and Informatics

Volumn 118, Issue , 2005, Pages 209-219

  De Grey, Aubrey ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE-RELATED; HUMAN AGING; LIFE SPAN; TECHNOLOGICAL BREAKTHROUGHS;

MEDICINE;

AGING; ANIMAL; ARTICLE; GERIATRICS; HUMAN; LONGEVITY; PHYSIOLOGY;

AGING; ANIMALS; GERIATRICS; HUMANS; LONGEVITY;

EID: 33645947673     PISSN: 09269630     EISSN: 18798365     Source Type: Book Series    
DOI: None     Document Type: Article

References (33)

1. A. Fire A et al., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature 391 (1998) 806-811
2. A.D.N.J. de Grey, The unfortunate influence of the weather on the rate of aging: why human caloric restriction or its emulation may only extend life expectancy by 2-3 years, Gerontology 51 (2005) 73-82
3. K.T. Coshigano et al., Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span, Endocrinology 144 (2003) 3799-3810
4. M. Holzenberger et al., IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice, Nature 421 (2003) 182-187
5. A.D.N.J. de Grey et al., Time to talk SENS: critiquing the immutability of human aging, Annals of the New York Academy of Sciences 959 (2002) 452-462
6. A.D.N.J. de Grey, An engineers approach to the development of real anti-aging medicine, Science of Aging Knowledge Environment 2003 (2003) p.1
7. H. Brody, Organization of the cerebral cortex III, Journal of Comparative Neurology 102 (1955) 511-556
8. L. Hayflick, The limited in vitro lifetime of human diploid cell strains, Experimental Cell Research 37 (1965) 614-636
9. L. Szilard, On the nature of the ageing process, Proceedings of the National Academy of Sciences USA 45 (1959) 35-45
10. R.G. Cutler, The dysdifferentiation hypothesis of mammalian aging and longevity. In E. Gicobini et al. (eds.), The Aging Brain: Cellular and Molecular Mechanisms of Aging in the Nervous System. Raven Press, New York, 1982, pp. 1-19
11. D. Harman, The biologic clock: the mitochondria Journal of the American Geriatrics Society 20 (1972) 145-147
12. B.L. Strehler et al., Rate and magnitude of age pigment accumulation in the human myocardium, Journal of Gerontology 14 (1959) 430-439
13. A. Alzheimer, Uber eine eigneartige Ehrankung der Himrinde, Allgemeine Z Psychiatr Psychish- Gerichtliche Medizin 64 (1907) 146-148
14. V.M. Monnier and A. Cerami, Nonenzymatic browning in vivo: possible process for aging of long-lived proteins, Science 211 (1981) 491-493
15. M.S. Rao and M.P. Mattson, Stem cells and aging: expanding the possibilities, Mechanisms of Ageing and Development 122 (2001) 713-734
16. N. Barzilai et al., Surgical removal of visceral fat reverses hepatic insulin resistance, Diabetes 48 (1999) 94-98
17. A.D.N.J. de Grey et al., Total deletion of in vivo telomere elongation capacity: an ambitious but possibly ultimate cure for all age-related human cancers, Annals of the New York Academy of Sciences 1019 (2004) 147-170
18. A.D.N.J. de Grey, Whole-body interdiction of lengthening of telomeres: a proposal for cancer prevention, Frontiers in Bioscience 10 (2005) 2420-2429
19. S.J. Zullo et al., Stable transformation of CHO Cells and human NARP cybrids confers oligomycin resistance (olir) following transfer of a mitochondrial DNA-encoded olir ATPase6 gene to the nuclear genome: a model system for mtDNA gene therapy, Rejuvenation Research 8 (2005) 18-28
20. A.D.N.J. de Grey, Bioremediation meets biomedicine: therapeutic translation of microbial catabolism to the lysosome, Trends in Biotechnology 20 (2002) 452-455
21. A.D.N.J. de Grey et al., Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases, Ageing Research Reviews, in press
22. D. Schenk et al., Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature 400 (1999) 173-177
23. D.A. Kass et al., Improved arterial compliance by a novel advanced glycation end-product crosslink breaker, Circulation 104 (2001) 1464-1470
24. A.D.N.J. de Grey, Escape velocity: why the prospect of extreme human life extension matters now, PLoS Biology 2 (2004) 723-726
25. S. Vasan et al., An agent cleaving glucose-derived protein crosslinks in vitro and in vivo, Nature 382 (1996) 275-278
26. M. Tuszynski et al., A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease, Nature Medicine 11 (2005) 551-555
27. E.A. Ryan et al., Five-year follow-up after clinical islet transplantation, Diabetes 54 (2005) 2060-2069
28. O. Lindvall and A. Bjorklund, Cell therapy in Parkinsons disease, Neurorx 1 (2004) 382-393
29. R.N. Felmer and J.A. Clark, The gene suicide system Ntr/CB1954 causes ablation of differentiated 3T3L1 adipocytes by apoptosis, Biology Research 37 (2004) 449-460
30. D. Berd, M-Vax: an autologous, hapten-modified vaccine for human cancer, Expert Reviews on Vaccines 3 (2004) 521-527
31. A.D.N.J. de Grey, Forces maintaining organellar genomes: is any as strong as genetic code disparity or hydrophobicity BioEssays 27 (2005) 436-446
32. D. Broderick, The Last Mortal Generation: How Science Will Alter Our Lives in the 21st Century, New Holland Publishers, London, 2000
33. A.D.N.J. de Grey, Resistance to debate on how to postpone ageing is delaying progress and costing lives, EMBO Reports 6 (2005) S49-S53